Trulieve director granted 23,438 share units

MILLNER THOMAS L reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

MILLNER THOMAS L reported acquisition or exercise transactions in this Form 4 filing.

Trulieve Cannabis Corp. director Thomas L. Millner received an equity compensation award in the form of 23,438 subordinate voting share units on March 13, 2026. These units were granted at no cash cost to him and increase his direct holdings to 72,543 shares.

The award is structured as restricted stock units (RSUs), each representing a contingent right to receive one Trulieve subordinate voting share. The RSUs will vest upon the earliest of the end of Millner’s board service, a change of control at Trulieve, or December 1, 2032, tying his compensation to long-term company performance.

Insider Trade Summary

Grant/Award: 23,438 shares

Grant/Award 1 txn

Insider MILLNER THOMAS L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Subordinate Voting Shares	23,438	$0.00	$0.00

Holdings After Transaction: Subordinate Voting Shares — 72,543 shares (Direct)

Footnotes (1)

1. F1. (Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2032.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Trulieve (TCNNF) report for Thomas L. Millner?

Trulieve reported that director Thomas L. Millner received a grant of 23,438 restricted stock units, each tied to one subordinate voting share. The award, granted at no cash cost, is part of his equity-based board compensation.

How many Trulieve (TCNNF) shares does Thomas L. Millner hold after this Form 4?

After the reported grant, Thomas L. Millner directly holds 72,543 Trulieve subordinate voting shares. This figure includes the impact of the 23,438 restricted stock units awarded as part of his director compensation package on March 13, 2026.

What type of equity did Trulieve (TCNNF) grant to director Thomas L. Millner?

Trulieve granted Thomas L. Millner restricted stock units (RSUs), with each RSU representing a contingent right to receive one subordinate voting share of Trulieve. These awards are non-cash compensation typically used to align directors’ interests with long-term shareholder value.

When do Thomas L. Millner’s Trulieve (TCNNF) RSUs vest?

The RSUs vest on the earliest of three events: the end of Millner’s service on Trulieve’s board, a change of control of Trulieve, or December 1, 2032. This long vesting horizon is designed to encourage sustained board engagement and oversight.

Did Thomas L. Millner buy Trulieve (TCNNF) shares on the open market?

No, the Form 4 shows a grant coded as an acquisition (code A), indicating compensation rather than an open-market purchase. The 23,438 units were awarded at a stated price of $0.00 per share, reflecting non-cash equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:56 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MILLNER THOMAS L

(Last) (First) (Middle)

C/O TRULIEVE CANNABIS CORP.

3494 MARTIN HURST ROAD

(Street)

TALLAHASSEE FL 32312

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Subordinate Voting Shares	03/13/2026		A		23,438(1)	A	$0	72,543	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. (Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2032.

	/s/ Eric Powers, as Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.